Business

In this article JPM Follow your favorite stocksCREATE FREE ACCOUNT JPMorgan Chase CEO and Chairman Jamie Dimon gestures as he speaks during the U.S. Senate Banking, Housing and Urban Affairs Committee oversight hearing on Wall Street firms, on Capitol Hill in Washington, D.C. Evelyn Hockstein | Reuters JPMorgan Chase said late Wednesday that the Federal
0 Comments
In this article GOOGL NFLX WBD DIS Follow your favorite stocksCREATE FREE ACCOUNT It’s been almost 20 years since the founding of Alphabet’s YouTube, and Hollywood still doesn’t really know what to do with it. YouTube, which effectively invented user-generated content, claims a daunting share of overall media consumption. And it’s no longer just dominating
0 Comments
In this article RIVN Follow your favorite stocksCREATE FREE ACCOUNT Workers assemble second-generation R1 vehicles at electric auto maker Rivian’s manufacturing facility in Normal, Illinois, U.S. June 21, 2024. Joel Angel Juarez | Reuters Volkswagen plans to invest up to $5 billion in electric vehicle startup Rivian, starting with an initial investment of $1 billion.
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug
0 Comments
The Shein logo can be seen on a smartphone, while the Chinese online retailer’s website is open on a laptop.  Monika Skolimowska | Picture Alliance | Getty Images China-founded e-commerce company Shein’s hopes of going public in the United States are growing slimmer by the day, according to experts, as rising tensions between Beijing and
0 Comments
In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related
0 Comments